Skip to main content
Figure 1 | BMC Complementary and Alternative Medicine

Figure 1

From: Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents

Figure 1

Samples inhibit PTP1B in a dose-dependent manner. Samples inhibit PTP1B in a dose-dependent manner. Different concentrations of the samples (0.002 – 0.1 mUnit/mL) were evaluated using the in vitro PTP1B enzyme assay. The dilution ratio is displayed on a logarithmic scale. The IC50 value was identified from the midpoint (cytotoxic activity = 50%) of the semi-log plot.

Back to article page